Dai WG - Search Results

1

Evaluation of drug precipitation of solubility-enhancing liquid formulations using milligram quantities of a new molecular entity (NME).

Dai WG, Dong LC, Shi X, Nguyen J, Evans J, Xu Y, Creasey AA. Dai WG, et al. J Pharm Sci. 2007 Nov;96(11):2957-69. doi: 10.1002/jps.20886. J Pharm Sci. 2007. PMID: 17705287

2

Screening method to identify preclinical liquid and semi-solid formulations for low solubility compounds: miniaturization and automation of solvent casting and dissolution testing.

Mansky P, Dai WG, Li S, Pollock-Dove C, Daehne K, Dong L, Eichenbaum G. Mansky P, et al. Among authors: dai wg. J Pharm Sci. 2007 Jun;96(6):1548-63. doi: 10.1002/jps.20799. J Pharm Sci. 2007. PMID: 17094139

3

Nanosizing of a drug/carrageenan complex to increase solubility and dissolution rate.

Dai WG, Dong LC, Song YQ. Dai WG, et al. Int J Pharm. 2007 Sep 5;342(1-2):201-7. doi: 10.1016/j.ijpharm.2007.04.032. Epub 2007 May 6. Int J Pharm. 2007. PMID: 17560055

4

Advanced screening assays to rapidly identify solubility-enhancing formulations: high-throughput, miniaturization and automation.

Dai WG, Pollock-Dove C, Dong LC, Li S. Dai WG, et al. Adv Drug Deliv Rev. 2008 Mar 17;60(6):657-72. doi: 10.1016/j.addr.2007.10.017. Epub 2007 Nov 9. Adv Drug Deliv Rev. 2008. PMID: 18222563 Review.

5

Preclinical assessment of the feasibility of applying controlled release oral drug delivery to a lead series of atypical antipsychotics.

Eichenbaum G, Pollock-Dove C, Nguyen J, Li S, Evans J, Borghys H, Kennis L, Dong L, van Osdol W, Dai W, Scicinski J, Chen J, Xu Y, Ashton D, Mackie C, Megens A. Eichenbaum G, et al. J Pharm Sci. 2006 Apr;95(4):883-95. doi: 10.1002/jps.20550. J Pharm Sci. 2006. PMID: 16489607

6

Characterization of physiochemical and biological properties of an insulin/lauryl sulfate complex formed by hydrophobic ion pairing.

Dai WG, Dong LC. Dai WG, et al. Int J Pharm. 2007 May 4;336(1):58-66. doi: 10.1016/j.ijpharm.2006.11.035. Epub 2006 Nov 19. Int J Pharm. 2007. PMID: 17174492

7

Parallel screening approach to identify solubility-enhancing formulations for improved bioavailability of a poorly water-soluble compound using milligram quantities of material.

Dai WG, Dong LC, Li S, Pollock-Dove C, Chen J, Mansky P, Eichenbaum G. Dai WG, et al. Int J Pharm. 2007 May 4;336(1):1-11. doi: 10.1016/j.ijpharm.2006.11.034. Epub 2006 Nov 17. Int J Pharm. 2007. PMID: 17178444

8

Combination of Pluronic/Vitamin E TPGS as a potential inhibitor of drug precipitation.

Dai WG, Dong LC, Li S, Deng Z. Dai WG, et al. Int J Pharm. 2008 May 1;355(1-2):31-7. doi: 10.1016/j.ijpharm.2007.12.015. Epub 2007 Dec 23. Int J Pharm. 2008. PMID: 18299178

9

Enhanced bioavailability of a poorly water-soluble weakly basic compound using a combination approach of solubilization agents and precipitation inhibitors: a case study.

Li S, Pollock-Dove C, Dong LC, Chen J, Creasey AA, Dai WG. Li S, et al. Among authors: dai wg. Mol Pharm. 2012 May 7;9(5):1100-8. doi: 10.1021/mp200352q. Epub 2012 Apr 13. Mol Pharm. 2012. PMID: 22376012

10

Enhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulation.

Dai WG, Dong LC, Song Y. Dai WG, et al. Int J Pharm. 2013 Nov 30;457(1):63-70. doi: 10.1016/j.ijpharm.2013.07.066. Epub 2013 Sep 1. Int J Pharm. 2013. PMID: 24004566

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters